David A Bull
Physician in Salt Lake City, UT
License number
Utah 187428-1205
Issued Date
Aug 13, 1992
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Organization information
See more information about David A Bull at bizstanding.comDavid Bull MD
30 N 1900 E, Salt Lake City, UT 84132
Industry:
Thoracic Surgery, Surgeons, Vascular Surgery
Phone:
(801) 581-5311 (Phone)
David Andrew Bull
Professional information
See more information about David A Bull at trustoria.com
Dr. David A Bull, Salt Lake City UT - MD (Doctor of Medicine)
Dr. David A Bull, Salt Lake City UT - MD (Doctor of Medicine)
Specialties:
Critical Care Surgery, Cardiac Surgery
Address:
University Utah Crdthrcc Sgy
30 N 1900 E SUITE 3C127, Salt Lake City 84132
(801) 581-5311 (Phone)
30 N 1900 E SUITE 3C127, Salt Lake City 84132
(801) 581-5311 (Phone)
Certifications:
Critical Care Surgery, 1991, General Surgery, 1991, Thoracic Cardiovascular Surgery, 2004, Vascular Surgery, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Utah Crdthrcc Sgy
30 N 1900 E SUITE 3C127, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
30 N 1900 E SUITE 3C127, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University of California At San Francisco
Graduated: 1985
U C S F Medical Center
U Ariz Hosps
University Of Utah
University of California At San Francisco
Graduated: 1985
U C S F Medical Center
U Ariz Hosps
University Of Utah
David A Bull, Salt Lake City UT
David A Bull, Salt Lake City UT
Specialties:
Vascular Surgeon
Address:
50 N Medical Dr, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
30 N 1900 E, Salt Lake City, UT 84132
Education:
University of California San Francisco, School of Medicine - Doctor of Medicine*
University Medical Center - Fellowship - Vascular Surgery (General Surgery)*
University Health Care - Residency - Surgery*
University Medical Center - Residency - Surgery*
UCSF Medical Center - Residency - Surgery*
University Medical Center - Fellowship - Vascular Surgery (General Surgery)*
University Health Care - Residency - Surgery*
University Medical Center - Residency - Surgery*
UCSF Medical Center - Residency - Surgery*
Board certifications:
American Board of Surgery Certification in Surgery*, American Board of Surgery Certification in Vascular Surgery (Surgery)*, American Board of Surgery Sub-certificate in Surgical Critical Care (Surgery)*, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery (Thoracic Surgery)*
David Bull, Salt Lake City UT
David Bull, Salt Lake City UT
Work:
Uumc Cardiothoracic Surgery
50 N Medical Dr, Salt Lake City, UT 84132 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148
50 N Medical Dr, Salt Lake City, UT 84132 Va Salt Lake City Health Care System
500 Foothill Dr, Salt Lake City, UT 84148
Organ Preservative Solution Containing Trehalose, Anti-Oxidant, Cations And An Energy Source
Organ Preservative Solution Containing Trehalose, Anti-Oxidant, Cations And An Energy Source
US Patent:
6365338, Apr 2, 2002
Filed:
Apr 27, 1999
Appl. No.:
09/299894
Inventors:
David A. Bull - Salt Lake City UT 84103
Bruce C. Reid - Bountiful UT 84010
James C. Stringham - Salt Lake City UT 84108
Shreekanth V. Karwande - Salt Lake City UT 84108
Bruce C. Reid - Bountiful UT 84010
James C. Stringham - Salt Lake City UT 84108
Shreekanth V. Karwande - Salt Lake City UT 84108
International Classification:
A01N 102
US Classification:
435 11
Abstract:
The present invention is organ and tissue preservation solutions that provide improved viability of an organ such as a heart or lung, or portion of the organ, for storage and transplantation. In particular, a solution contains trehalose, magnesium sulfate, calcium chloride, heparin, dextran, nitroglycerin, adenosine, L-arginine, allopurinol, reduced glutathione, db-cylic AMP and potassium phosphate.
Ventricular Assist Device Capable Of Implantation Of Stem Cells
Ventricular Assist Device Capable Of Implantation Of Stem Cells
US Patent:
8241198, Aug 14, 2012
Filed:
Nov 5, 2007
Appl. No.:
12/513310
Inventors:
David A. Bull - Salt Lake City UT, US
Rafe C. Connors - Bountiful UT, US
Harold M. Erickson - Cora WY, US
James Yockman - West Jordan UT, US
Sung Wan Kim - Salt Lake City UT, US
Rafe C. Connors - Bountiful UT, US
Harold M. Erickson - Cora WY, US
James Yockman - West Jordan UT, US
Sung Wan Kim - Salt Lake City UT, US
Assignee:
University of Utah Foundation - Salt Lake City UT
International Classification:
A61M 1/12
US Classification:
600 16, 604 601, 604 609
Abstract:
A biologic ventricular assist device that also has the capability to capture, grow, and administer stem cells to regenerate and restore damaged myocardium in the heart. The device works in conjunction with a traditional ventricular assist device and possesses an additional external path or tube that is in-line with the path of the ventricular assist device. The external path allows for the administration of stem cells, genes, genetically modified cells or other therapeutic biologic or pharmacologic agents, as well as leading to a stem cell collecting accessory () that captures circulating stem cells. The stem cell collecting accessory is also associated with a chamber () for culturing the captured stem cells. The cultured stem cells can be delivered back to the heart by an electro-mechanical or ultrasound/echocardiographic delivery system that runs through the external path back into the ventricular assist device and allows for the delivery of the stem cells, or other therapeutic biologic or pharmacologic agents, directly into the internal chambers of the heart. Administering the stem cells, genes, genetically modified cells or other therapeutic biologic or pharmacologic agents, either alone or in combination, to the heart allows the myocardium to regenerate and repair itself even while the heart is attached to the ventricular assist device, ultimately allowing the heart to regenerate, recover and allow the VAD to be removed.
Ventricular Assist Device Capable Of Implantation Of Stem Cells
Ventricular Assist Device Capable Of Implantation Of Stem Cells
US Patent:
2013012, May 16, 2013
Filed:
Jun 14, 2012
Appl. No.:
13/523334
Inventors:
David A. Bull - Salt Lake City UT, US
Rafe C. Connors - Keswick VA, US
Harold M. Erickson - Cora WY, US
James Yockman - West Jordan UT, US
Sung Wan Kim - Salt Lake City UT, US
Rafe C. Connors - Keswick VA, US
Harold M. Erickson - Cora WY, US
James Yockman - West Jordan UT, US
Sung Wan Kim - Salt Lake City UT, US
Assignee:
UNIVERSITY OF UTAH FOUNDATION - Salt Lake City UT
International Classification:
A61K 35/34, C12N 5/071
US Classification:
600439, 604522
Abstract:
A biologic ventricular assist device that also has the capability to capture, grow, and administer stem cells to regenerate and restore damaged myocardium in the heart. The device works in conjunction with a traditional ventricular assist device and possesses an additional external path or tube that is in-line with the path of the ventricular assist device. The external path allows for the administration of stem cells, genes, genetically modified cells or other therapeutic biologic or pharmacologic agents, as well as leading to a stem cell collecting accessory that captures circulating stem cells. The stem cell collecting accessory is also associated with a chamber for culturing the captured stem cells. The cultured stem cells can be delivered back to the heart by an electro-mechanical or ultrasound/echocardiographic delivery system that runs through the external path back into the ventricular assist device and allows for the delivery of the stem cells, or other therapeutic biologic or pharmacologic agents, directly into the internal chambers of the heart. Administering the stem cells, genes, genetically modified cells or other therapeutic biologic or pharmacologic agents, either alone or in combination, to the heart allows the myocardium to regenerate and repair itself even while the heart is attached to the ventricular assist device, ultimately allowing the heart to regenerate, recover and allow the VAD to be removed.
Brown Fat Cell Compositions And Methods
Brown Fat Cell Compositions And Methods
US Patent:
2013007, Mar 21, 2013
Filed:
Jun 28, 2012
Appl. No.:
13/536564
Inventors:
Francisco Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
Assignee:
BIORESTORATIVE THERAPIES, INC. - Jupiter FL
International Classification:
A61K 35/12, C12N 5/071, C12N 5/07, A61K 35/36
US Classification:
424 937, 435325, 424574, 435 29, 435 61, 435377
Abstract:
Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.
Brown Fat Cell Compositions And Methods
Brown Fat Cell Compositions And Methods
US Patent:
2014001, Jan 16, 2014
Filed:
Jul 1, 2013
Appl. No.:
13/932562
Inventors:
Francisco Javier Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
International Classification:
C12N 5/077
US Classification:
435377
Abstract:
Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.
Brown Fat Cell Compositions And Methods
Brown Fat Cell Compositions And Methods
US Patent:
2014002, Jan 23, 2014
Filed:
Jul 1, 2013
Appl. No.:
13/932468
Inventors:
Francisco Javier Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
International Classification:
A61K 35/12, G01N 33/50
US Classification:
424 937, 435378, 424574, 435 34, 435 71, 435 61, 435377
Abstract:
Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.
Brown Fat Cell Compositions And Methods
Brown Fat Cell Compositions And Methods
US Patent:
2014003, Feb 6, 2014
Filed:
Jul 1, 2013
Appl. No.:
13/932544
Inventors:
Francisco Javier Silva - Miramar FL, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
Mark Weinreb - Woodbury NY, US
Amit N. Patel - Salt Lake City UT, US
David A. Bull - Salt Lake City UT, US
International Classification:
G01N 33/50
US Classification:
435 61, 435 29
Abstract:
Methods of developing and using cell lines, such as stem cell lines, for therapeutic or cosmetic use. In one embodiment the cell lines are used to treat a wide range of degenerative and metabolic disorders including, but not limited to, obesity, diabetes, hypertension, and cardiac deficiency. Also described are methods of using such cell lines to screen for compounds that play a role in regulating a variety of processes.